Physician profile
Craig B Thompson
NPI 1336180710
$4,758,440.97
in general payments reported to CMS, 2019-2025
4 companies · $1.9M in 2025
The $1.9M reported for 2025 was more than what 99% of Medical Oncology providers received nationally (typical 2025 total: $1,158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $23K · 2020: $8,000 · 2021: $12K · 2022: $1.0M · 2023: $259K · 2024: $1.5M · 2025: $1.9M.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $3.6M · Travel and Lodging: $25K · Food and Beverage: $6,370.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $3,645,468.48 |
| Travel and Lodging | $24,660.51 |
| Food and Beverage | $6,370.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Pharmaceuticals, INC. | $2,708,149.09 | 2022-2025 | |
| Merck Sharp & Dohme LLC | $1,990,923.53 | 2024-2025 | |
| Agios Pharmaceuticals, INC. | $59,250.00 | 2019-2023 | |
| Abiomed | $118.35 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Craig Thompson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.